| n (%) | |
| Masaoka | |
| Stage I | 23 (35.4%) |
| Stage II | 18 (27.7%) |
| Stage III | 11 (16.9%) |
| Stage IV | 13 (20.0%) |
| WHO (n = 60) | |
| A | 4 (6.7%) |
| AB | 9 (15.0%) |
| B | 46 (76.7%) |
| Mixed | 1 (1.6%) |